Neogen ROE 2006-2019 | NEOG

Current and historical return on equity (ROE) values for Neogen (NEOG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Neogen ROE for the three months ending May 31, 2019 was 9.86%.
Neogen ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-05-31 $0.06B $0.64B 9.83%
2019-02-28 $0.06B $0.62B 10.49%
2018-11-30 $0.07B $0.60B 11.55%
2018-08-31 $0.07B $0.58B 12.15%
2018-05-31 $0.06B $0.56B 12.13%
2018-02-28 $0.06B $0.54B 11.47%
2017-11-30 $0.05B $0.52B 10.56%
2017-08-31 $0.05B $0.49B 9.75%
2017-05-31 $0.04B $0.47B 9.68%
2017-02-28 $0.04B $0.45B 9.60%
2016-11-30 $0.04B $0.44B 9.49%
2016-08-31 $0.04B $0.42B 9.33%
2016-05-31 $0.04B $0.40B 9.38%
2016-02-29 $0.04B $0.39B 9.44%
2015-11-30 $0.03B $0.38B 9.50%
2015-08-31 $0.03B $0.37B 9.56%
2015-05-31 $0.03B $0.35B 9.90%
2015-02-28 $0.03B $0.34B 9.93%
2014-11-30 $0.03B $0.33B 10.30%
2014-08-31 $0.03B $0.32B 10.02%
2014-05-31 $0.03B $0.31B 10.09%
2014-02-28 $0.03B $0.29B 10.16%
2013-11-30 $0.03B $0.28B 10.60%
2013-08-31 $0.03B $0.27B 11.45%
2013-05-31 $0.03B $0.26B 11.53%
2013-02-28 $0.03B $0.25B 11.59%
2012-11-30 $0.03B $0.24B 11.16%
2012-08-31 $0.02B $0.23B 10.69%
2012-05-31 $0.02B $0.22B 10.62%
2012-02-29 $0.02B $0.21B 11.01%
2011-11-30 $0.02B $0.20B 11.47%
2011-08-31 $0.02B $0.20B 12.50%
2011-05-31 $0.02B $0.19B 13.14%
2011-02-28 $0.02B $0.18B 13.25%
2010-11-30 $0.02B $0.17B 13.29%
2010-08-31 $0.02B $0.16B 13.29%
2010-05-31 $0.02B $0.15B 12.50%
2010-02-28 $0.02B $0.15B 11.59%
2009-11-30 $0.02B $0.14B 11.30%
2009-08-31 $0.01B $0.14B 10.98%
2009-05-31 $0.01B $0.13B 11.41%
2009-02-28 $0.01B $0.13B 11.84%
2008-11-30 $0.01B $0.12B 12.36%
2008-08-31 $0.01B $0.12B 11.98%
2008-05-31 $0.01B $0.11B 11.59%
2008-02-29 $0.01B $0.11B 11.14%
2007-11-30 $0.01B $0.10B 10.58%
2007-08-31 $0.01B $0.10B 9.97%
2007-05-31 $0.01B $0.09B 9.20%
2007-02-28 $0.01B $0.09B 9.97%
2006-11-30 $0.01B $0.09B 9.49%
2006-08-31 $0.01B $0.08B 10.37%
2006-05-31 $0.01B $0.07B 11.48%
2006-02-28 $0.01B $0.06B 8.55%
2005-11-30 $0.01B $0.06B 8.89%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.002B $0.414B
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
InfuSystems Holdings (INFU) United States $0.105B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00